Article ID Journal Published Year Pages File Type
8442557 European Journal of Cancer 2015 9 Pages PDF
Abstract
Overall, 15% of breast cancer survivors treated with docetaxel report PN 1-3 years after treatment with a significant negative impact on HRQOL.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
Authors
, , , ,